A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bio Techne Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 24,100 shares of TECH stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,100
Previous 42,000 42.62%
Holding current value
$1.8 Million
Previous $2.96 Million 41.61%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $1.11 Million - $1.51 Million
-17,900 Reduced 42.62%
24,100 $1.73 Million
Q1 2024

May 15, 2024

SELL
$65.98 - $77.09 $943,514 - $1.1 Million
-14,300 Reduced 25.4%
42,000 $2.96 Million
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $6.27 Million - $9.28 Million
-118,668 Reduced 67.82%
56,300 $4.34 Million
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $1.41 Million - $1.87 Million
-20,900 Reduced 10.67%
174,968 $11.9 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $13.9 Million - $16.2 Million
-188,600 Reduced 49.05%
195,868 $16 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $11.3 Million - $13.6 Million
157,500 Added 69.39%
384,468 $28.5 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $12.5 Million - $54.8 Million
155,476 Added 217.47%
226,968 $18.8 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $13.9 Million - $19.3 Million
49,300 Added 222.15%
71,492 $20.3 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $13.9 Million - $19.3 Million
49,300 Added 222.15%
71,492 $20.3 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $2.16 Million - $3.01 Million
6,692 Added 43.17%
22,192 $7.69 Million
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $1.09 Million - $1.51 Million
-3,092 Reduced 16.63%
15,500 $6.71 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $5.74 Million - $6.61 Million
12,592 Added 209.87%
18,592 $9.62 Million
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $2.67 Million - $3.23 Million
6,000 New
6,000 $2.91 Million
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $1.68 Million - $2.19 Million
-6,792 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$232.22 - $282.96 $1.58 Million - $1.92 Million
6,792 New
6,792 $1.68 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $439,075 - $518,394
-2,392 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$188.72 - $215.43 $451,418 - $515,308
2,392 New
2,392 $499,000
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $403,395 - $558,444
-2,736 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$144.9 - $165.58 $434,700 - $496,740
-3,000 Reduced 52.3%
2,736 $405,000
Q1 2018

May 15, 2018

BUY
$131.46 - $151.04 $754,054 - $866,365
5,736 New
5,736 $866,000
Q4 2017

Feb 14, 2018

SELL
$121.17 - $134.75 $705,815 - $784,918
-5,825 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $661,661 - $721,018
5,825
5,825 $704,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.93B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.